Asked by: Andrew Bridgen (Independent - North West Leicestershire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many and what proportion of patients who were moved from hospitals to (a) care and (b) nursing homes subsequently died of (i) covid-19 and (ii) other causes within (A) 7, (B) 14, (C) 28, (D) 56 and (E) 112 days of being moved.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The information requested is not held centrally.
Asked by: Andrew Bridgen (Independent - North West Leicestershire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many patients were moved from hospitals to (a) care and (b) nursing homes to create space for anticipated covid-19 patients in England and Wales in (i) March and (ii) April 2020.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The information requested is not held centrally.
Asked by: Andrew Bridgen (Independent - North West Leicestershire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, (a) with reference to NICE guideline NG163, published 3 April 2020, by what process that guideline was commissioned, (b) by what processes the NHS decided to procure Midazolam for use in patient care, including end-of-life care and (c) by what process the NHS decided on the quantity of Midazolam it would procure in each of the last four years.
Answered by Will Quince
The National Institute of Health and Care Excellence’s (NICE) guideline NG163 published in 2020 was commissioned in accordance with an established agreement between NHS England and NICE. The focus at that time was given to providing rapid guidance on the management of affected patients with COVID-19. A number of NICE’s COVID-19 rapid guidelines were incorporated into a single guideline for the management of COVID-19 in children and adults (NG191).
During the pandemic there was an increase in demand for, and consequently in the United Kingdom’s purchase of a number of medicines, including midazolam, to support the care of COVID-19 patients in intensive care and at the end of life. National Health Service purchasing decisions are made by individual trusts against national procurement frameworks. Volumes are calculated based on their forecast consumption.
Asked by: Andrew Bridgen (Independent - North West Leicestershire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what budget provision his Department has made for costs associated with vaccine harms in the next five years.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Vaccine Damage Payment Scheme amount included in the Annual Report and Accounts, was £9,889,743 as of 31 March 2022. The information can be found in ‘Note 16 Provisions for liabilities and charges’ on page 353. The £9,889,743 is contained in the ‘other’ value of £4,078,443,000. As the amount is not material to the accounts, it was contained in the ‘other’ category with other provisions.
Asked by: Andrew Bridgen (Independent - North West Leicestershire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department holds data on the vaccine status of people who died after 31 May 2022.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The UK Health Security Agency (UKHSA) does hold data on the vaccine status of people who died after 31 May 2022.
UKHSA uses the data on the vaccination status of people who have died to produce monthly COVID-19 Vaccine Surveillance reports which can be found at the following link:
https://www.gov.uk/government/publications/covid-19-vaccine-weekly-surveillance-reports
This covers an extensive range of measures of vaccine effectiveness, including demonstrating effectiveness against infection, transmission, hospitalisation and mortality.
Asked by: Andrew Bridgen (Independent - North West Leicestershire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many and what proportion of clinical NHS staff have received a covid-19 booster vaccination in the most recent period for which data is available.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The United Kingdom Health Security Agency publish monthly reports on seasonal influenza and COVID-19 vaccine uptake in frontline healthcare workers. Data published to the end of November 2022 showed that in 165 NHS trusts providing a return, 338,602 frontline healthcare workers had had a COVID-19 vaccine since 1 September 2022, an uptake of 36.3%.